Research output per year
Research output per year
Personal profile
Personal information
Mark has a background in Biomedical Sciences and Health Technology Assessment (BSc, Radboudumc/Radboud University Nijmegen) as well as in Management and Entrepreneurship in the Life Sciences (MSc, Vrije Universiteit Amsterdam). As a PhD researcher, he analyzes the dynamics of intangible resources and intellectual property (IP) rights in Life Sciences industries. Mobilizing these hidden organizational assets to leverage their potential in technological innovation and stakeholder value creation is at the center of his research.
Ancillary activities
No ancillary activities
Ancillary activities are updated daily
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Academic qualification
Biomedical Sciences (Health Technology Assessment), Bachelor, RadboudUMC
Management and Entrepreneurship in Health and Life Sciences, Master, Vrije Universiteit Amsterdam
Keywords
- T201 Patents. Trademarks
- intellectual property rights
- HD28 Management. Industrial Management
- innovation management
- R&D management
- intangible resources
- RA0421 Public health. Hygiene. Preventive Medicine
- outbreak management
- vaccine innovation
- RM Therapeutics. Pharmacology
- clinical trials
- QR Microbiology
- microbiota
- probiotics
User created Keywords
- distributed ledger technology
- blockchain
Fingerprint
Dive into the research topics where Mark van der Waal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Blockchain-facilitated sharing to advance outbreak R&D
van der Waal, M. B., Dos S Ribeiro, C., Ma, M., Haringhuizen, G. B., Claassen, E. & van de Burgwal, L. H. M., 15 May 2020, In: Science. 368, 6492, p. 719-721 3 p.Research output: Contribution to Journal › Article › Academic › peer-review
Open AccessFile109 Downloads (Pure) -
Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model
Van de Burgwal, L. H. M., Ribeiro, C. D. S., Van der Waal, M. B. & Claassen, E., 26 Nov 2018, In: Vaccine. 36, 49, p. 7496-7508 13 p.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access -
Accelerating microbiota product development: The Societal Impact Value Cycle as a conceptual model to shape and improve public-private valorization processes
Van de Burgwal, L. H. M., Van der Waal, M. B. & Claassen, E., Dec 2018, In: PharmaNutrition. 6, 4, p. 157-168 12 p.Research output: Contribution to Journal › Review article › Academic › peer-review
Open Access -
Leveraging academic knowledge in the innovation ecosystem: The Societal Impact Value Cycle as a toolbox
van de Burgwal, L. H. M., van der Waal, M. B. & Claassen, H. J. H. M., 2018, Rotterdam: Stichting Maatschappij en Onderneming. 72 p.Research output: Book / Report › Book › Academic
Open Access -
Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector: Incorporating User Value and Societal Needs in Therapeutic Interventions
Timmis, J. K., van der Waal, R., Herz, J., van der Waal, M., Claassen, E. & van de Burgwal, L., Nov 2021, In: Health (Irvine). 13, 11, p. 1365-1395 31 p.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access